vs

Side-by-side financial comparison of CG Oncology, Inc. (CGON) and TOP Financial Group Ltd (TOP). Click either name above to swap in a different company.

TOP Financial Group Ltd is the larger business by last-quarter revenue ($2.9M vs $2.3M, roughly 1.2× CG Oncology, Inc.). TOP Financial Group Ltd runs the higher net margin — 6.6% vs -1779.0%, a 1785.7% gap on every dollar of revenue.

CG Oncology, Inc. is a clinical-stage biotechnology company focused on developing innovative targeted immunotherapies for urological cancers including non-muscle invasive bladder cancer. It primarily operates in the U.S. market, advancing pipeline candidates to address unmet medical needs for patients with limited treatment options.

Sun Life Financial Inc. is a Canadian financial services company headquartered in Toronto, Ontario. Founded in 1865, it operates internationally in life insurance, wealth management, and asset management. As of 2024, the company manages over CAD$1.3 trillion in assets and serves clients in Canada, the United States, Asia, and other markets.

CGON vs TOP — Head-to-Head

Bigger by revenue
TOP
TOP
1.2× larger
TOP
$2.9M
$2.3M
CGON
Higher net margin
TOP
TOP
1785.7% more per $
TOP
6.6%
-1779.0%
CGON

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CGON
CGON
TOP
TOP
Revenue
$2.3M
$2.9M
Net Profit
$-41.3M
$190.5K
Gross Margin
Operating Margin
-2097.3%
Net Margin
-1779.0%
6.6%
Revenue YoY
409.2%
Net Profit YoY
-29.9%
EPS (diluted)
$-0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGON
CGON
TOP
TOP
Q4 25
$2.3M
Q3 25
$1.7M
$2.9M
Q2 25
$0
Q4 24
$456.0K
Q1 24
$529.0K
Net Profit
CGON
CGON
TOP
TOP
Q4 25
$-41.3M
Q3 25
$-43.8M
$190.5K
Q2 25
$-41.4M
Q4 24
$-31.8M
Q1 24
$-16.9M
Operating Margin
CGON
CGON
TOP
TOP
Q4 25
-2097.3%
Q3 25
-3069.0%
Q2 25
Q4 24
-8344.1%
Q1 24
-4247.4%
Net Margin
CGON
CGON
TOP
TOP
Q4 25
-1779.0%
Q3 25
-2629.5%
6.6%
Q2 25
Q4 24
-6973.7%
Q1 24
-3200.8%
EPS (diluted)
CGON
CGON
TOP
TOP
Q4 25
$-0.52
Q3 25
$-0.57
Q2 25
$-0.54
Q4 24
$-0.47
Q1 24
$-0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGON
CGON
TOP
TOP
Cash + ST InvestmentsLiquidity on hand
$742.2M
$14.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$752.6M
$35.0M
Total Assets
$791.6M
$64.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGON
CGON
TOP
TOP
Q4 25
$742.2M
Q3 25
$680.3M
$14.8M
Q2 25
$661.1M
Q4 24
$742.0M
Q1 24
$566.5M
Stockholders' Equity
CGON
CGON
TOP
TOP
Q4 25
$752.6M
Q3 25
$687.6M
$35.0M
Q2 25
$670.4M
Q4 24
$733.4M
Q1 24
$568.9M
Total Assets
CGON
CGON
TOP
TOP
Q4 25
$791.6M
Q3 25
$729.9M
$64.1M
Q2 25
$701.4M
Q4 24
$754.8M
Q1 24
$579.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGON
CGON
TOP
TOP
Operating Cash FlowLast quarter
$-36.2M
Free Cash FlowOCF − Capex
$-36.2M
FCF MarginFCF / Revenue
-1560.0%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-124.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGON
CGON
TOP
TOP
Q4 25
$-36.2M
Q3 25
$-38.9M
Q2 25
$-28.0M
Q4 24
$-20.7M
Q1 24
$-26.0M
Free Cash Flow
CGON
CGON
TOP
TOP
Q4 25
$-36.2M
Q3 25
$-39.0M
Q2 25
$-28.0M
Q4 24
$-20.9M
Q1 24
$-26.0M
FCF Margin
CGON
CGON
TOP
TOP
Q4 25
-1560.0%
Q3 25
-2340.4%
Q2 25
Q4 24
-4577.0%
Q1 24
-4919.5%
Capex Intensity
CGON
CGON
TOP
TOP
Q4 25
0.3%
Q3 25
5.8%
Q2 25
Q4 24
45.8%
Q1 24
2.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons